Symposium 13: Health effects of Natural Products: from molecular structure to the biological response
Tracks
Track 5
| Wednesday, July 15, 2026 |
| 11:15 AM - 1:15 PM |
Details
The proposed Natural Products Pharmacology symposium has been conceived to provide an up-to-date knowledge in all aspects of the basic and translational pharmacology of natural products including plant- and fruit-derived natural products as well as natural product as a pure chemical entity. The symposium will cover specific areas related to discovery and preclinical development based on metabolomics, biological activities in the cardiovascular, metabolic and cancer domain, defined mechanisms of action, and novel targets or therapeutic indications. The aim of the symposium is also to promote networking strategies between junior and senior scientists as well as students interested in the health effects of Natural Products, between pharmaceutical industrial partners and the Natural Products researchers community, and to strengthen a working collaboration between the scientists in the field of Natural Products and the Natural Products Section of IUPHAR.
Speaker
Dr Yali Liu
Nanjing University of Chinese Medicine
Natural ginseng-derived nanoparticles for integrated anti-cancer strategies: Immune checkpoint enhancement and tumor vaccine delivery
Biography
Dr. Yali Liu is an Assistant Professor at the State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, China. She obtained her Ph.D. in Pharmaceutics from the University of Tübingen, Germany. Her research focuses on the discovery and biomedical application of bioactive natural products, particularly plant-derived extracellular vesicle-like particles (PDEVs). Dr. Liu’s recent work has explored the therapeutic relevance of these vesicles in inflammatory conditions affecting the skin and gut, as well as their emerging potential in tumor immune modulation, with an emphasis on targeted delivery and cross-species communication. Dr. Liu is also open to collaborative opportunities in natural product-based therapeutics.
Session chair
Valerie Schini-kerth
Strasbourg University
Michael Spedding
President
Spedding Research Solutions SAS
